Global Information
회사소개 | 문의 | 비교리스트

정형외과 재생의료 시장 : 치료 유형(줄기세포 요법, 플라즈마 기반 요법, 조직공학), 적응 질환, 최종사용자, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Orthopedic Regenerative Medicine Market, by Treatment Type (Stem Cell Therapy, Plasma Based Therapy, Tissue Engineering ), by Disease Indication, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045558
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,733,000 PDF (Single User License)
US $ 7,000 ₩ 8,919,000 PDF (Multi User License)
US $ 10,000 ₩ 12,742,000 PDF (Enterprise User License)


정형외과 재생의료 시장 : 치료 유형(줄기세포 요법, 플라즈마 기반 요법, 조직공학), 적응 질환, 최종사용자, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Orthopedic Regenerative Medicine Market, by Treatment Type (Stem Cell Therapy, Plasma Based Therapy, Tissue Engineering ), by Disease Indication, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

정형외과 재생의료 시장은 정형외과 질환 치료용 제품 승인 취득에 대한 주력, 공동 연구, 파트너십, 계약 등 시장 기업의 무기적인 활동 증가에 의해 예측기간 중 성장이 가속화될 것으로 예측됩니다.

세계의 정형외과 재생의료(Orthopedic Regenerative Medicine) 시장에 대해 조사했으며, 시장 역학, 역학, 제품 발매, 규제 시나리오, 부문/지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 개요

  • 보고서 개요
  • 개요
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 영향 분석
  • 규제 시나리오
  • PEST 분석
  • 최근의 제품 발매/승인
  • 역학
  • 인수합병(M&A)

제4장 COVID-19의 영향 분석

  • 공급망에 대한 영향
  • 연구개발에 대한 영향
  • 정부 이니셔티브

제5장 세계의 정형외과 재생의료 시장 : 치료 유형별(2017-2028년, 금액)

  • 서론
  • 줄기세포 치료
  • 동종뼈
  • 자가뼈
  • 골이식
  • 혈장 요법
  • 인체조직공학
  • 동종이식

제6장 세계의 정형외과 재생의료 시장 : 적응 질환별(2017-2028년, 금액)

  • 서론
  • 골관절 질환
  • 류마티스 관절염
  • 인대 손상
  • 활액낭염
  • 골다공증

제7장 세계의 정형외과 재생의료 시장 : 최종사용자별(2017-2028년, 금액)

  • 서론
  • 병원/클리닉
  • 정형외과 전문센터
  • 기타

제8장 세계의 정형외과 재생의료 시장 : 지역별(2017-2028년, 금액)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 구도

  • 기업 개요
    • Ortho Regenerative Technologies Inc.
    • Personalized stem cells Inc.
    • Anika Therapeutics Inc.
    • Arthrex Inc.
    • Baxter International Inc.
    • Conmed Corporation
    • Aziyo Biologics
    • Curasan Inc.
    • Swiss biomed Orthopedics AG
    • Octane Medical Inc.
    • Stryker Corporation
    • Carmell Therapeutics Corporation
    • Zimmer Holdings
    • Smith &Nephew plc.
    • NuVasive Inc.
  • 애널리스트의 견해

제10장 섹션

LSH 22.02.17

Regenerative medicines can be consider as manufacturing of pharmaceuticals for the regrowth of cells, replacing damaged cells, organs, or tissues .The developing methods for medicines includes the generation, tissue engineering, and therapeutic stem cells and production of artificial organs. Regenerative orthopedic medicines can help in healing damaged tissues, and improve the discomfort and pain which occurred due to musculoskeletal diseases. These regenerative medicines can be developed by using stem cells, plasma-rich sources, biological tissues, and bone marrow. Orthopedic regenerative medicines help in healing injuries of ligament, tendon, bone, spinal disc, muscle, cartilage, and musculoskeletal tissues.

Market Dynamics

Market players are indulged in receiving approvals from regulatory authorities for the treatment of orthopedic diseases, which is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, on June 28, 2021, Curasan AG, a company which produce regenerative medicines, has received approval from U.S. Food and Drug Administration (FDA) and The National Health Surveillance Agency (ANVISA) Brazilian regulatory agency for CERASORB Foam for use with antibiotics which is a B-TCP collagen matrix which use for delivering antimicrobials to wound surface to inhibit microbes capable of healing. The major use of this foam is minimizing the risk of reinfection of the infected area by combining it with antibiotics.

Increasing inorganic activities by market players such as collaborations, partnerships, and agreements is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, on January 14, 2021, Bone Therapeutics, which is a manufacturer of cell therapy products, signed partnership with Rigener and, a company which develops and produces cGMP products, used for cell-gene therapy. The aim of this partnership was to develop products based on bone therapeutics by expanding research for therapeutic portfolio. This partnership will be focused on augmented bone forming cells that are programmed for specific task and by studying the new mechanisms of action for gene modifications for orthopedic regenerative medicines.

Key features of the study:

  • This report provides an in-depth analysis of the global orthopedic regenerative medicine market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global orthopedic regenerative medicine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study includes Ortho Regenerative Technologies Inc., Personalized stem cells Inc., Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Conmed Corporation, Aziyo Biologics, Curasan Inc., Swiss biomed Orthopedics AG, Octane Medical Inc., Stryker Corporation, Carmell Therapeutics Corporation, Zimmer Holdings, Smith & Nephew plc., and NuVasive Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global orthopedic regenerative medicine market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthopedic regenerative medicine market

Detailed Segmentation:

  • Global Orthopedic Regenerative Medicine Market, By Treatment Type :
    • Stem Cell Therapy
    • Allogeneic Bones
    • Autogeneic Bones
    • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
    • Allograft
  • Global Orthopedic Regenerative Medicine Market, By Disease Indication:
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • Global Orthopedic Regenerative Medicine Market, By End User :
    • Hospitals and Clinics
    • Orthopedic Specialty Centers
    • Others
  • Global Orthopedic Regenerative Medicine Market, By Region:
    • North America
  • By Treatment Type:
    • Stem Cell Therapy
      • Allogeneic Bones
      • Autogeneic Bones
      • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
      • Allograft
  • By Disease Indication :
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • By End User:
    • Hospitals and Clinics
    • Orthopedic Specialty Centers
    • Others
  • By Country:
    • U.S.
    • Canada
    • Latin America
  • By Treatment Type:
    • Stem Cell Therapy
      • Allogeneic Bones
      • Autogeneic Bones
      • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
      • Allograft
  • By Disease Indication :
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • By End User:
    • Hospitals and Clinics
    • Orthopedic Specialty Centers
    • Others
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • By Treatment Type:
    • Stem Cell Therapy
      • Allogeneic Bones
      • Autogeneic Bones
      • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
      • Allograft
  • By Disease Indication :
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • By End User:
    • Hospitals and Clinics
    • Orthopedic Specialty Centers
    • Others
  • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Treatment Type:
    • Stem Cell Therapy
      • Allogeneic Bones
      • Autogeneic Bones
      • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
      • Allograft
  • By Disease Indication :
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • By End User:
    • Hospitals and Clinics
    • Orthopedic Specialty Centers
    • Others
  • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • By Treatment Type:
    • Stem Cell Therapy
      • Allogeneic Bones
      • Autogeneic Bones
      • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
      • Allograft
  • By Disease Indication :
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • By End User:
    • Hospitals and Clinics
    • Orthopedic Specialty Centers
    • Others
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Treatment Type:
    • Stem Cell Therapy
      • Allogeneic Bones
      • Autogeneic Bones
      • Bone Grafting
    • Plasma Based Therapy
    • Tissue Engineering
      • Allograft
  • By Disease Indication :
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Bursitis
    • Osteoporosis
  • By End User:
    • Hospitals and Clinics
    • Orthopedic specialty centers
    • Others
  • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Ortho Regenerative Technologies Inc. *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Personalized stem cells Inc.
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Baxter International Inc.
  • Conmed Corporation
  • Aziyo Biologics
  • Curasan Inc.
  • Swiss biomed Orthopedics AG
  • Octane Medical Inc.
  • Stryker Corporation
  • Carmell Therapeutics Corporation
  • Zimmer Holdings
  • Smith & Nephew plc.
  • NuVasive Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Treatment Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. COVID - 19 Impact Analysis

  • Impact on Supply Chain
  • Impact on Research and Development
  • Government Initiatives

5. Global Orthopedic Regenerative Medicine Market, By Treatment Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Stem Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Allogeneic Bones
  • Autogeneic Bones
  • Bone Grafting
  • Plasma Based Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Allograft

6. Global Orthopedic Regenerative Medicine Market, By Disease Indication , 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Osteoarticular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Rheumatoid Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Ligament Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Bursitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Osteoporosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

7. Global Orthopedic Regenerative Medicine Market, By End User, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Orthopedic Specialty Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

8. Global Orthopedic Regenerative Medicine Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Treatment Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Treatment Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Treatment Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Treatment Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Treatment Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Treatment Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Ortho Regenerative Technologies Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Personalized stem cells Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Anika Therapeutics Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Arthrex Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Baxter International Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Conmed Corporation
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Aziyo Biologics
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Curasan Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Swiss biomed Orthopedics AG
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Octane Medical Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Stryker Corporation
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Carmell Therapeutics Corporation
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Zimmer Holdings
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Smith & Nephew plc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • NuVasive Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q